MUI LEE: Open Payments
NPI 1366703118 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,176 in 110 payments from 21 companies in 2025. Trend: 2023 $2,949 · 2024 $2,876 · 2025 $2,176
Food & beverage: $1,897Education: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $532 |
| ABBVIE INC. | 33 | $355 |
| UCB, Inc. | 9 | $233 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| Lilly USA, LLC | 5 | $126 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $94 |
| GENZYME CORPORATION | 4 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
Products named: TREMFYA, RINVOQ, DUPIXENT, Bimzelx, COSENTYX, TALTZ, SKYRIZI, JUBLIA.
Industry payments across TX — which companies pay providers there.
